Tibet Weixinkang Medicine Co., Ltd. (SHA:603676)
China flag China · Delayed Price · Currency is CNY
10.60
0.00 (0.00%)
Apr 30, 2026, 3:00 PM CST

Tibet Weixinkang Medicine Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4,5834,5484,3304,5396,9284,051
Market Cap Growth
3.04%5.04%-4.60%-34.48%71.03%6.52%
Enterprise Value
3,5423,5393,2823,7106,1503,412
Last Close Price
10.6010.529.679.6414.478.30
PE Ratio
21.1519.5317.5921.2139.1542.23
PS Ratio
3.944.013.333.434.953.92
PB Ratio
2.973.083.133.395.683.80
P/TBV Ratio
3.013.133.163.485.793.84
P/FCF Ratio
33.3444.7613.7626.6541.1235.20
P/OCF Ratio
20.5524.5111.6218.8228.1423.73
EV/Sales Ratio
3.053.122.522.814.403.30
EV/EBITDA Ratio
11.8811.6412.2319.7532.2327.40
EV/EBIT Ratio
14.2013.6514.7825.5839.8036.72
EV/FCF Ratio
25.7734.8310.4321.7936.5129.64
Debt / Equity Ratio
0.010.010.000.010.010.01
Debt / EBITDA Ratio
0.040.040.020.040.030.04
Debt / FCF Ratio
0.090.110.020.050.030.04
Net Debt / Equity Ratio
-0.67-0.66-0.73-0.66-0.66-0.66
Net Debt / EBITDA Ratio
-3.54-3.19-3.78-4.72-4.20-5.67
Net Debt / FCF Ratio
-7.57-9.56-3.22-5.21-4.75-6.14
Asset Turnover
0.600.610.720.770.890.72
Inventory Turnover
8.768.6015.0518.3724.3422.67
Quick Ratio
3.313.212.792.732.502.16
Current Ratio
3.743.703.083.042.772.41
Return on Equity (ROE)
14.37%16.27%18.06%16.71%15.47%9.35%
Return on Assets (ROA)
8.10%8.71%7.64%5.27%6.11%4.07%
Return on Invested Capital (ROIC)
39.73%48.58%47.92%32.94%38.42%20.19%
Return on Capital Employed (ROCE)
15.70%17.10%15.60%10.50%12.30%8.60%
Earnings Yield
4.73%5.12%5.68%4.71%2.55%2.37%
FCF Yield
3.00%2.23%7.27%3.75%2.43%2.84%
Dividend Yield
3.08%-3.54%2.96%1.62%1.93%
Payout Ratio
72.58%70.19%72.25%45.72%38.80%41.90%
Buyback Yield / Dilution
-0.61%0.15%-0.90%0.83%-3.50%0.08%
Total Shareholder Return
2.47%0.15%2.64%3.79%-1.88%2.00%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.